Analysis of Dosage Mutation in PARK2 among Korean Patients with Early-Onset or Familial Parkinson's Disease

BACKGROUND AND PURPOSE: There is some controversy regarding heterozygous mutations of the gene encoding parkin (PARK2) as risk factors for Parkinson's disease (PD), and all previous studies have been performed in non-Asian populations. Dosage mutation of PARK2, rather than a point mutation or s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chu, Min Kyung, Kim, Won Chan, Choi, Jung Mi, Hong, Jeong-Hoon, Kang, Suk Yun, Ma, Hyeo-Il, Kim, Yun Joong
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Neurological Association 2014
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4101102/
https://ncbi.nlm.nih.gov/pubmed/25045378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3988/jcn.2014.10.3.244
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados